Delivery Order SPE2DR25D2212-SPE2DR26FB9GS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,536.62 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,507.31 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,128.45 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed price contract. The award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at $6,095.49 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) on May 13, 2025, with an ultimate completion date of May 14, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performs at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) valued at approximately $22K, with an ultimate completion date of September 3, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is performed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $36,663.92 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $8,638.51 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with an ultimate completion date of June 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,488.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml, with an ultimate completion date of November 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $10,555.27. This firm fixed-price delivery order, which is scheduled for completion by November 4, 2025, represents a competitive award with no set-aside designation. The award was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,353.27 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on November 7, 2025, with completion expected by November 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9GSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,227.31 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a broad portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic areas. The company's extensive federal contract history with DLA demonstrates its capability to meet competitive procurement standards and support the medical supply chain requirements of the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This specific delivery order for Ozempic, a diabetes management medication, exemplifies the company's ongoing role in providing specialized pharmaceutical products to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/20/25 |